#BEGIN_DRUGCARD DB00639

# AHFS_Codes:
84:04.08.08

# ATC_Codes:
G01AF15

# Absorption:
Following vaginal administration of butoconazole nitrate vaginal cream, 2% to 3 women, 1.7% (range 1.3-2.2%) of the dose was absorbed on average.

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Femstat
Femstat 3
Gynazole-1

# CAS_Registry_Number:
64872-77-1

# ChEBI_ID:
Not Available

# Chemical_Formula:
C19H17Cl3N2S

# Chemical_IUPAC_Name:
1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)sulfanyl]butyl]-1H-imidazole

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
2248417

# Description:
Butoconazole is an imidazole antifungal used in gynecology.

# Dosage_Forms:
Cream	Intravaginal

# Drug_Category:
Antifungal Agents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Approved
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
6.7

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Nitrate salt: 0.26 mg/ml (practically insoluble)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Butoconazole

# HET_ID:
Not Available

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C19H17Cl3N2S/c20-15-7-4-14(5-8-15)6-9-16(12-24-11-10-23-13-24)25-19-17(21)2-1-3-18(19)22/h1-5,7-8,10-11,13,16H,6,9,12H2

# InChI_Key:
InChIKey=SWLMUYACZKCSHZ-UHFFFAOYSA-N

# Indication:
For the local treatment of vulvovaginal candidiasis (infections caused by Candida)

# KEGG_Compound_ID:
C08066

# KEGG_Drug_ID:
D00880

# LIMS_Drug_ID:
639

# Mechanism_Of_Action:
The exact mechanism of the antifungal action of butoconazole is unknown, however, it is presumed to function as other imidazole derivatives via inhibition of steroid synthesis. Imidazoles generally inhibit the conversion of lanosterol to ergosterol via the inhibition of the enzyme cytochrome P450 14&alpha;-demethylase, resulting in a change in fungal cell membrane lipid composition. This structural change alters cell permeability and, ultimately, results in the osmotic disruption or growth inhibition of the fungal cell.

# Melting_Point:
~159Â°C with decomposition (nitrate salt)

# Molecular_Weight_Avg:
411.776

# Molecular_Weight_Mono:
410.017802365

# Organisms_Affected:
Fungi, yeast and protozoans

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/myc1567.shtml

# Pathways:
Not Available

# PharmGKB_ID:
PA164781353

# Pharmacology:
Butoconazole is an imidazole derivative that has fungicidal activity <i>in vitro</i> against <i>Candida</i> spp. and has been demonstrated to be clinically effective against vaginal infections due to <i>Candida albicans</i>. <i>Candida albicans</i> has been identified as the predominant species responsible for vulvovaginal candidasis.

# Predicted_LogP_Hydrophobicity:
6.7

# Predicted_LogS:
-5.7

# Predicted_Water_Solubility:
8.18e-04 g/l

# Primary_Accession_No:
DB00639

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
47472

# PubChem_Substance_ID:
46508016

# RxList_Link:
http://www.rxlist.com/cgi/generic2/butoconazole.htm

# Salts:
Not Available

# Secondary_Accession_No:
APRD00834

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
ClC1=CC=C(CCC(CN2C=CN=C2)SC2=C(Cl)C=CC=C2Cl)C=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Butoconazol [INN-Spanish]
Butoconazole nitrate
Butoconazolum [INN-Latin]

# Synthesis_Reference:
Not Available

# Toxicity:
Oral, rat: LD<sub>50</sub> = >1720 mg/kg.

# Update_Date:
2013-02-08 16:19:31 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Butoconazole

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
2184984	Pfaller MA, Riley J, Koerner T: Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans. Diagn Microbiol Infect Dis. 1990 Jan-Feb;13(1):31-5.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Not Available

# Drug_Target_1_General_References:
Not Available

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
7160

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
Not Available

# Drug_Target_1_Name:
Ergosterol, Candida albicans

# Drug_Target_1_Number_of_Residues:
0

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
Not Available

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
Not Available

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Not Available

# Drug_Target_1_SwissProt_Name:
Not Available

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
Not Available

# Drug_Target_1_Transmembrane_Regions:
Not Available

#END_DRUGCARD DB00639
